Related references
Note: Only part of the references are listed.B regulatory cells in allergy
Siyuan Ma et al.
IMMUNOLOGICAL REVIEWS (2021)
Regulatory B cells: TIM-1, transplant tolerance, and rejection
Aravind Cherukuri et al.
IMMUNOLOGICAL REVIEWS (2021)
Regulatory B cells in cancer
Daniel Michaud et al.
IMMUNOLOGICAL REVIEWS (2021)
Invariant natural killer T cells balance B cell immunity
Elizabeth A. Leadbetter et al.
IMMUNOLOGICAL REVIEWS (2021)
Regulatory B cells in respiratory health and diseases
Madhvi Menon et al.
IMMUNOLOGICAL REVIEWS (2021)
Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
Charles A. Roach et al.
FRONTIERS IN NEUROLOGY (2021)
Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID-19
Alice R. Burton et al.
IMMUNOLOGICAL REVIEWS (2021)
Regulation of neuroinflammation by B cells and plasma cells
Angela Wang et al.
IMMUNOLOGICAL REVIEWS (2021)
The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer
Akshay J. Patel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Combined proinflammatory cytokine and cognate activation of invariant natural killer T cells enhances anti-DNA antibody responses
Saikiran K. Sedimbi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The Role of Antibodies in the Pathogenesis of Multiple Sclerosis
Xiaoli Yu et al.
FRONTIERS IN NEUROLOGY (2020)
Effector and regulatory B cells in immune-mediated kidney disease
Kristine Oleinika et al.
NATURE REVIEWS NEPHROLOGY (2019)
Discrepancies in the Tumor Microenvironment of Spontaneous and Orthotopic Murine Models of Pancreatic Cancer Uncover a New Immunostimulatory Phenotype for B Cells
Sarah Spear et al.
FRONTIERS IN IMMUNOLOGY (2019)
CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells
K. Oleinika et al.
NATURE COMMUNICATIONS (2018)
CD9+ Regulatory B Cells Induce T Cell Apoptosis via IL-10 and Are Reduced in Severe Asthmatic Patients
Carole Brosseau et al.
FRONTIERS IN IMMUNOLOGY (2018)
Human regulatory B cells in health and disease: therapeutic potential
Claudia Mauri et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non-Small Cell Lung Cancer Patients
Tullia C. Bruno et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
Gilles Salles et al.
ADVANCES IN THERAPY (2017)
Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis
Francesca Gorini et al.
BLOOD (2017)
The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction
M. Virginia Gentilini et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression
Xiao Xiao et al.
CANCER DISCOVERY (2016)
A regulatory CD9+ B-cell subset inhibits HDM-induced allergic airway inflammation
F. Braza et al.
ALLERGY (2015)
Regulatory B Cells: Origin, Phenotype, and Function
Elizabeth C. Rosser et al.
IMMUNITY (2015)
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity
Yaron Carmi et al.
NATURE (2015)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al.
SEMINARS IN CANCER BIOLOGY (2015)
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
Masanori Matsumoto et al.
IMMUNITY (2014)
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
Ping Shen et al.
NATURE (2014)
B-lymphocyte lineage cells and the respiratory system
Atsushi Kato et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses
Willem van de Veen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Lipid-Antigen Presentation by CD1d+ B Cells Is Essential for the Maintenance of Invariant Natural Killer T Cells
Anneleen Bosma et al.
IMMUNITY (2012)
Allergen-Specific Transforming Growth Factor-β-Producing CD19(+)CD5(+) Regulatory B-Cell (Br3) Responses in Human Late Eczematous Allergic Reactions to Cow's Milk
Jae Ho Lee et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis - A 52-week phase II trial
R. T. Naismith et al.
NEUROLOGY (2010)
Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids
Ruth Pepper et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
JCW Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prevention of arthritis by interleukin 10-producing B cells
C Mauri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Expression profiling of B cell chronic lymphocytic leukemia suggests deficient CD1-mediated immunity, polarized cytokine response, altered adhesion and increased intracellular protein transport and processing of leukemic cells
Z Zheng et al.
LEUKEMIA (2002)
B cells regulate autoimmunity by provision of IL-10
S Fillatreau et al.
NATURE IMMUNOLOGY (2002)
Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation
A Mizoguchi et al.
IMMUNITY (2002)
Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes
JCW Edwards et al.
RHEUMATOLOGY (2001)
Share Paper
